General Information

CFS ROSCO-Global Health & Biotech
Colonial First State Investments Limited
FSF0158AU
Equity World Other
Not Rated
Superannuation Fund
1 Nov 2000
$18.07 million (as at 31 Jul 2017)
$1.6479 (as at 22 Aug 2017)
$1.643 (as at 22 Aug 2017)

Fund performance (31 Jul 2017)

NOTE : returns for periods greater than 1 year are annualised
  1 Month % 3 Month % 6 Month % 1 Year % p.a. 2 Year % p.a. 3 Year % p.a. 5 Year % p.a. 10 Year % p.a.
Total return -3.07 0.04 8.93 6.51 -1 16.82 23.03 11.05
Growth return -3.07 0.04 8.93 6.51 -1 16.82 - 11.05
Income return 0 0 0 0 0 0 - 0

Market index (MSCI World NR AUD)

Total return -1.62 -1.68 5.2 10.55 3.11 12.2 17.97 5.19
Your data is being crunched

Fund Performance Comparison

This fund is benchmarked against the {{ selectedModel.benchmark.name }} index.

This fund's fees are: {{ mer | percentage:2 }}

Returns {{ fund.name }} Peers Benchmark Peers Fees
1 Month {{ fund.returns.return1Month | percentage:2 }} {{ fund.benchmark.peers.returns.return1Month | percentage:2 }} {{ fund.benchmark.index.returns.return1Month | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
3 Months {{ fund.returns.return3Month | percentage:2 }} {{ fund.benchmark.peers.returns.return3Month | percentage:2 }} {{ fund.benchmark.index.returns.return3Month | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
6 Months {{ fund.returns.return6Month | percentage:2 }} {{ fund.benchmark.peers.returns.return6Month | percentage:2 }} {{ fund.benchmark.index.returns.return6Month | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
1 Year {{ fund.returns.return1Year | percentage:2 }} {{ fund.benchmark.peers.returns.return1Year | percentage:2 }} {{ fund.benchmark.index.returns.return1Year | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
3 Years {{ fund.returns.return3Year | percentage:2 }} {{ fund.benchmark.peers.returns.return3Year | percentage:2 }} {{ fund.benchmark.index.returns.return3Year | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
5 Years {{ fund.returns.return5Year | percentage:2 }} {{ fund.benchmark.peers.returns.return5Year | percentage:2 }} {{ fund.benchmark.index.returns.return5Year | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}
10 Years {{ fund.returns.return10Year | percentage:2 }} {{ fund.benchmark.peers.returns.return10Year | percentage:2 }} {{ fund.benchmark.index.returns.return10Year | percentage:2 }} {{ fund.benchmark.peers.mer | percentage:2 }}

Relative Fund Performance

Asset Allocation (31 Jul 2017)

Australian Equities 0%
International Equities 95.14%
Cash 4.86%
Property 0%
Fixed Interest 0%
Alternatives 0%
Asset Allocation

Objectives and Strategy

To provide long-term capital growth by predominantly investing in companies around the world, whose primary business is in the fields of pharmaceuticals, biotechnology, healthcare services and medical products. The option aims to outperform the MSCI All Country Health Care Index over rolling three-year periods before fees and taxes.
The option's strategy is to add value by investing, over the medium to long term, in quality companies, with sustainable earnings per share growth and sensible valuations, whose primary business is healthcare related. The option does not hedge currency risk.

Offer information

Standard entry fee 4%
Indirect Cost Ratio (ICR) 2.27% (as at 22 May 2017) (Estimated)
Minimum initial investment $1,000.00
Minimum additional investments
Minimum redemption amount

© 2017 Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.